IDXG 0.85 (-68.52%)
US46062X3035Medical Diagnostics & ResearchDiagnostics & Research

Interpace Biosciences (IDXG) Competitor Comparison

We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - IDXG ranking 42 / 58

These are the competitors of Interpace Biosciences in the industry Diagnostics & Research ranked by linearity 10 years
1. Ortho Clinical Diagnostics Holdings OCDX
33.4
2. National Research NRC
20.02
3. Guardant Health GH
16.49
4. Illumina ILMN
12.28
5. Neogen NEOG
10.48
6. Anixa Biosciences ANIX
10.43
7. Olink Holding OLK
8.11
8. Global Cord Blood CO
5.67
9. Inotiv NOTV
5.59
10. Fulgent Genetics FLGT
5.47
11. DarioHealth DRIO
4.86
12. Pacific Biosciences of California PACB
4.06
13. Sotera Health SHC
4.02
14. Syneos Health SYNH
3.71
15. Sera Prognostics SERA
3.63
16. Exact Sciences EXAS
3.27
17. Co-Diagnostics CODX
3.21
18. Myriad Genetics MYGN
3.21
19. Bioventus BVS
3.15
20. Enzo Biochem ENZ
3.08
21. Qiagen QGEN
2.9
22. Psychemedics PMD
2.77
23. Twist Bioscience TWST
2.51
24. NeoGenomics NEO
2.36
25. Aspira Womens Health AWH
2.28
26. Exagen XGN
2.23
27. Meridian Bioscience VIVO
2.1
28. MDxHealth MDXH
1.99
29. MaxCyte MXCT
1.93
30. Charles River Laboratories CRL
1.92
31. Biodesix BDSX
1.92
32. bioAffinity Technologies BIAF
1.9
33. Personalis PSNL
1.88
34. CareDx CDNA
1.82
35. Prenetics Global PRE
1.76
36. Quest Diagnostics DGX
1.74
37. Organovo Holdings ONVO
1.66
38. Neuronetics STIM
1.62
39. Trinity Biotech TRIB
1.57
40. Laboratory Corp of America Holdings LH
1.52
41. SeqLL SQL
1.42
42. Interpace Biosciences IDXG
1.33
43. PerkinElmer PKI
1.15
44. IQVIA Holdings IQV
1.13
45. Icon ICLR
1.1
46. Precipio PRPO
1.09
47. DexCom DXCM
1.06
48. Mettler-Toledo MTD
0.92
49. Agilent Technologies A
0.87
50. IDEXX Laboratories IDXX
0.85
51. Waters WAT
0.77
52. Danaher DHR
0.71
53. Thermo Fisher Scientific TMO
0.7
54. Heska HSKA
0.52
55. Natera NTRA
0.45
56. RadNet RDNT
0.4
57. Lantheus Holdings LNTH
0.33
58. Medpace Holdings MEDP
0.22

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.